Journal of Human Reproductive Science
Home Ahead of Print Current Issue Archives
   Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size    Users online: 739


 
   Table of Contents     
LETTER TO EDITOR  
Year : 2021  |  Volume : 14  |  Issue : 3  |  Page : 325
 

Do basal luteinizing hormone and luteinizing hormone/follicle-stimulating hormone ratio have significance in prognosticating the outcome of In vitro fertilization cycles in polycystic ovary syndrome?


1 Private Academic Consultant Center, Bangkok, Thailand
2 Department of Community Medicine, Dr. DY Patil University, Pune, Maharashtra, India

Date of Submission17-Jun-2021
Date of Decision20-Jul-2021
Date of Acceptance02-Aug-2021
Date of Web Publication28-Sep-2021

Correspondence Address:
Dr. Pathum Sookaromdee
Private Academic Consultant, Bangkok
Thailand
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jhrs.jhrs_87_21

Rights and Permissions

 



How to cite this article:
Sookaromdee P, Wiwanitkit V. Do basal luteinizing hormone and luteinizing hormone/follicle-stimulating hormone ratio have significance in prognosticating the outcome of In vitro fertilization cycles in polycystic ovary syndrome?. J Hum Reprod Sci 2021;14:325

How to cite this URL:
Sookaromdee P, Wiwanitkit V. Do basal luteinizing hormone and luteinizing hormone/follicle-stimulating hormone ratio have significance in prognosticating the outcome of In vitro fertilization cycles in polycystic ovary syndrome?. J Hum Reprod Sci [serial online] 2021 [cited 2021 Dec 5];14:325. Available from: https://www.jhrsonline.org/text.asp?2021/14/3/325/326927




Dear Editor,

We would like to share ideas on the publication “Do basal luteinizing hormone and luteinizing hormone/follicle-stimulating hormone (LH/FSH) ratio have significance in prognosticating the outcome of in vitro fertilization (IVF) cycles in polycystic ovary syndrome?” Singh et al. noted that “The elevated basal day 2/3 LH and LH/FSH ratio do not impair the outcome of GnRH antagonist protocol treated IVF/intracytoplasmic sperm injection cycles in polycystic ovary syndrome women.[1]” Regarding the diagnostic value of basal day 2/3 LH and LH/FSH ratio, there are many confounding factors that might affect the result. First, certain genetic polymorphisms can have an effect. In a report by Deswal et al., luteinizing hormone and LH receptor gene polymorphisms played important role in determining LH and LH/FSH ratio.[2] Furthermore, assay interference might occur and result in aberrant LH and LH/FSH ratio.[3] Segal et al. reported that heterophile antibodies are examples of those interferences.[3]

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
   References Top

1.
Singh N, Mishra N, Dogra Y. Do basal luteinizing hormone and luteinizing hormone/follicle-stimulating hormone ratio have significance in prognosticating the outcome of in vitro fertilization cycles in polycystic ovary syndrome? J Hum Reprod Sci 2021;14:21-7.  Back to cited text no. 1
  [Full text]  
2.
Deswal R, Nanda S, Dang AS. Association of luteinizing hormone and lh receptor gene polymorphism with susceptibility of polycystic ovary syndrome. Syst Biol Reprod Med 2019;65:400-8.  Back to cited text no. 2
    
3.
Segal DG, DiMeglio LA, Ryder KW, Vollmer PA, Pescovitz OH. Assay interference leading to misdiagnosis of central precocious puberty. Endocrine 2003;20:195-9.  Back to cited text no. 3
    




 

Top
Print this article  Email this article
             

    

 
   Search
 
  
    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
    Article in PDF (498 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    References

 Article Access Statistics
    Viewed200    
    Printed6    
    Emailed0    
    PDF Downloaded37    
    Comments [Add]    

Recommend this journal